Genomics (NASDAQ:TXG – Get Free Report) had its price objective reduced by equities researchers at Stifel Nicolaus from ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

Full Year 2024 Results Key Financial Results Revenue: US$610.8m (down 1.3% from FY ...

Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...

DoubleDown Interactive (NASDAQ:DDI – Get Free Report) had its price target cut by equities research analysts at Northland Securities from $21.00 to $18.00 in a research report issued to clients and ...

DoorDash (NASDAQ:DASH – Get Free Report) had its price objective hoisted by analysts at Citigroup from $211.00 to $240.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm ...

National Bank Financial boosted their FY2025 earnings per share (EPS) estimates for Torex Gold Resources in a report released ...

On Wednesday, 10x Genomics Inc (NASDAQ:TXG) reported a fourth-quarter EPS loss of $(0.40), missing the consensus estimate of ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 8.5% in the pre-market session after the company reported ...

PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results ...

TD Cowen analyst Dan Brennan lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps a Hold rating on the shares. The ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...